CHENG Jun, et al. Combining testing gastric juice and serum levels of CA72 - 4、A19 - 9 and CEA for the clinical value of gastric cancer[J]. Journal of Chongqing Medical University, 2003,(1):17-20.
CHENG Jun, et al. Combining testing gastric juice and serum levels of CA72 - 4、A19 - 9 and CEA for the clinical value of gastric cancer[J]. Journal of Chongqing Medical University, 2003,(1):17-20. DOI: 10.13406/j.cnki.cyxb.2003.01.006.
Objective:To explore the clinical value of gastric cancer by combined testing of the gastric juice and serum levels of CA72 - 4
CA19 - 9 and CEA. Methods :The gastric juice and serum levels of CA72 - 4
CA19 - 9 and CEA in 32 cases of all stages of gastric cancer and 20 cases of benign gastric disorders were determined preoperatively using IRMA method. Results: The results showed that the gastric juice
serum levels and the sensitivity rates of CA72 - 4
CA19 ~ 9 and CEA were significantly higher ( P < 0.01)) in the gastric cancer group than in the benigh gastric disorders group. The gastric juice levels of CA72 - 4
CA19 - 9 and CEA were also higher than the serum levels in the gastric cancer group. The results showed that the sensitivity rate of combining assaying gastric juice CA19 - 9
serum CA19-9 and serum CA72 - 4 was 78. 13 % . The gastric juice and serum levels of CA72 - 4
CA19 - 9 in early stage ( Ⅰ
Ⅱ ) of gastric cancer were higher than those in progressive and late stage ( Ⅲ
Ⅳ ). Conclusion : The reasonable preopera-tive combining test might be of high value for early diagnosis
predicting the diffusion and metastasis
improving the therapeutic effect and prognosis for gastric cancer